Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

  • Business News
  • April 29, 2026, 10:30 UTC
  • 1
  • 1 comments

Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy

Market reaction Comment Full text

DELEK LOGISTICS PARTNERS, LP (DKL)

  • Business News
  • April 29, 2026, 10:30 UTC
  • 1
  • 1 comments

Delek Logistics Reports First Quarter 2026 Results

Market reaction Comment Full text

AGIOS PHARMACEUTICALS, INC. (AGIO)

  • Business News
  • April 29, 2026, 10:30 UTC
  • 1
  • 1 comments

Agios Reports First Quarter 2026 Financial Results and Provides Business Update

Market reaction Comment Full text

DELEK US HOLDINGS, INC. (DK)

  • Business News
  • April 29, 2026, 10:30 UTC
  • 1
  • 1 comments

Delek US Holdings Reports First Quarter 2026 Results

Market reaction Comment Full text

COSTAMARE INC. (CMRE)

  • Business News
  • April 29, 2026, 10:29 UTC
  • 1
  • 1 comments

Costamare Inc. Reports Results For The First Quarter Ended March 31, 2026

Market reaction Comment Full text

GE HEALTHCARE TECHNOLOGIES INC. (GEHC)

  • Business News
  • April 29, 2026, 10:20 UTC
  • 1
  • 1 comments

GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth

Market reaction Comment Full text

GE HEALTHCARE TECHNOLOGIES INC. (GEHC)

  • Business News
  • April 29, 2026, 10:20 UTC
  • 1
  • 1 comments

GE HealthCare reports first quarter 2026 financial results

Market reaction Comment Full text

BRINKER INTERNATIONAL, INC (EAT)

  • Business News
  • April 29, 2026, 10:15 UTC
  • 1
  • 1 comments

BRINKER INTERNATIONAL REPORTS THIRD QUARTER OF FISCAL 2026 RESULTS AND UPDATES FISCAL 2026 GUIDANCE

Market reaction Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • April 29, 2026, 10:09 UTC
  • 1
  • 1 comments

[Press Release] HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for wAIHA

Market reaction Comment Full text

BANK HAPOALIM B.M. (POLI)

  • Business News
  • April 29, 2026, 10:07 UTC
  • 1
  • 1 comments

Court rejected a motion for a class action regarding the deposit of deposits by remote means - continuation

Market reaction Comment Full text
  • Previous
  • 82
  • 83
  • 84
  • 85
  • 86
  • Next

Search

News categories

  • Technical Exchange News(12156)
  • Event(5810)
  • SEC News(258056)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152465)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin